Losartan Cost in Michigan 2026: Cash Price, Medicaid, and Insurance Guide

What Does Losartan Actually Cost in Michigan Right Now?

Generic losartan is one of the most affordable prescription drugs in Michigan in 2026. Cash-pay patients typically pay between $7 and $14 per month for a 30-tablet supply of 25 mg, 50 mg, or 100 mg tablets at major Michigan chains, according to GoodRx retail data. The manufacturer list price for branded Cozaar sits near $80 per month, but fewer than 2% of Michigan patients fill the brand-name version.

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA in 1995 for hypertension [1]. It blocks the AT1 receptor, reducing vasoconstriction and aldosterone secretion, which lowers blood pressure by an average of 10 to 15 mmHg systolic in clinical practice [2]. The drug is also FDA-approved for reducing stroke risk in hypertensive patients with left ventricular hypertrophy and for slowing the progression of diabetic nephropathy in patients with type 2 diabetes [1].

Retail pricing varies by pharmacy. CVS, Walgreens, Rite Aid, Meijer, and Kroger Michigan locations all stock generic losartan. GoodRx coupons routinely bring the price to $7, $9 at Meijer or Kroger pharmacy counters. Costco and Sam's Club pharmacies in Michigan often list the drug at $6, $9 for 90 tablets without any coupon, which translates to $2, $3 per month at a 30-tablet equivalent [3].

The price difference between the 50 mg and 100 mg strengths is generally negligible at the cash-pay level, often less than $2 per month. Patients who require 100 mg doses do not pay a meaningful premium over those on 50 mg at most Michigan pharmacies.

How Michigan Medicaid Covers Losartan

Michigan Medicaid (Healthy Michigan Plan) covers losartan for hypertension, heart failure, and diabetic nephropathy, but requires prior authorization (PA) in most managed care plans. The PA process typically asks the prescriber to document that the patient has an established diagnosis of hypertension, diabetic nephropathy, or heart failure, and that the drug is being used within FDA-labeled indications [4].

Once PA is approved, beneficiaries generally pay $1, $3 per prescription under Michigan Medicaid cost-sharing rules for generic drugs, depending on their specific managed care organization (MCO). Michigan Medicaid contracts with several MCOs including Molina Healthcare of Michigan, Blue Cross Complete, and Priority Health Government, each of which administers losartan under its own formulary tier but must comply with the state's preferred drug list (PDL) [5].

The American Diabetes Association's 2024 Standards of Care explicitly recommend ARB therapy for patients with type 2 diabetes and hypertension or chronic kidney disease, stating: "In patients with type 2 diabetes and hypertension, ACE inhibitors or ARBs are preferred agents" [6]. This guideline language gives prescribers a strong clinical basis for PA submissions when documenting diabetic nephropathy.

Medicaid patients denied PA on a first attempt have the right to an expedited appeal under Michigan Department of Health and Human Services (MDHHS) rules. Appeals must be filed within 90 days of the denial notice, and expedited reviews are completed within 72 hours when a prescriber certifies medical urgency [5].

For dual-eligible patients (Medicare and Medicaid), losartan appears on most Medicare Part D formularies at Tier 1 or Tier 2. The 2026 Medicare Part D redesign capped out-of-pocket drug costs at $2,000 annually, which effectively eliminates catastrophic-phase spending for patients who take losartan alongside other cardiometabolic drugs [4].

Which Michigan Insurance Plans Cover Losartan?

Virtually every commercial insurance plan operating in Michigan covers generic losartan. Blue Cross Blue Shield of Michigan, Priority Health, HAP, and McLaren Health Plan all list it on their 2026 formularies at Tier 1 or Tier 2 [7]. Tier 1 generics typically carry copays of $0, $10 per 30-day supply. Tier 2 generics usually cost $15, $40 per 30-day supply depending on the plan design.

Employer-sponsored plans administered by Aetna, Cigna, and UnitedHealthcare in Michigan similarly place losartan at Tier 1 in the vast majority of plan designs, reflecting the drug's long generic history and its inclusion on most national preferred drug lists [7].

Patients can confirm their specific copay by checking the formulary lookup tool on their insurer's website or calling the member services number on their insurance card. The formulary tier may differ between a plan's 30-day retail and 90-day mail-order supplies, and mail-order often offers a lower per-day cost.

High-deductible health plans (HDHPs) require patients to meet their deductible before copays apply. For Michigan employees on HDHPs with a $1,500 deductible, the first few fills of losartan may be charged at the pharmacy's negotiated rate, typically $10, $15, before the deductible resets their cost to the copay level [8].

The JNC 8 guideline panel recommends ARBs as one of four first-line antihypertensive drug classes for the general adult population, which means losartan's coverage status is supported by major cardiology and nephrology guidelines and is rarely challenged during insurance review [9].

Is Compounded Losartan Legal in Michigan?

Compounded losartan prepared by a Michigan-licensed 503A pharmacy is legal under both federal and Michigan state law, provided the pharmacy holds an active Michigan Board of Pharmacy compounding registration and the prescription is patient-specific [10]. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound drugs from bulk active pharmaceutical ingredients when they meet specific conditions, including a valid prescription and no compounding of commercially available drug copies in a manner that presents no demonstrable difference [10].

Compounded losartan is not a copy of the FDA-approved tablet in the sense that 503A pharmacies often prepare it in alternative forms, such as oral suspensions or specialized strengths not commercially available (for example, 12.5 mg oral suspension for pediatric or renally impaired patients). A 503A pharmacy in Michigan may also compound losartan in combination with other antihypertensives when a clinician documents a specific patient need [11].

Cost for compounded losartan varies widely. Some 503A pharmacies that partner with telehealth platforms charge $0 per month when bundled with a clinical membership fee, while independent compounding pharmacies may charge $30, $60 per month for custom suspensions. Patients should verify that their chosen Michigan pharmacy holds a current Resident Pharmacy license from the Michigan Board of Pharmacy before filling a compounded losartan prescription [11].

503B outsourcing facilities, which operate under FDA oversight rather than state pharmacy boards, may not dispense directly to patients without a prescription and are generally not the source of retail compounded losartan in Michigan.

What Does the Clinical Evidence Say About Losartan?

Losartan's efficacy in hypertension and cardiovascular risk reduction is well established across multiple large randomized controlled trials, which also explains why payers treat it as a preferred agent.

The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193) published in The Lancet in 2002 compared losartan 50 to 100 mg to atenolol 50 to 100 mg over a mean follow-up of 4.8 years in patients with hypertension and electrocardiographic LVH. Losartan reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% relative to atenolol (hazard ratio 0.87 to 95% CI 0.77, 0.98, P=0.021), driven largely by a 25% reduction in fatal and non-fatal stroke [12].

The RENAAL trial (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan, N=1,513) demonstrated that losartan 50 to 100 mg reduced the risk of doubling of serum creatinine by 25% and end-stage renal disease by 28% relative to placebo in patients with type 2 diabetes and nephropathy, independent of blood pressure lowering (P<0.02 for both endpoints) [13].

A 2021 Cochrane systematic review of ARBs for hypertension concluded that losartan and other ARBs produce comparable blood pressure reductions to ACE inhibitors with a significantly lower rate of drug discontinuation due to cough, one of the most common reasons patients stop ACE inhibitors [14]. The review analyzed data from more than 25,000 participants across 68 trials.

These outcomes directly influence formulary placement. Payers place drugs with large, replicated outcome data in preferred tiers to encourage use, which is one reason losartan's generic versions remain Tier 1 across most Michigan formularies [7].

How to Use GoodRx and Manufacturer Savings Cards in Michigan

GoodRx operates in Michigan and provides free discount cards accepted at more than 6,000 Michigan pharmacy locations. Presenting a GoodRx coupon at Meijer, Kroger, or Walmart pharmacy typically reduces the cash price of 30 tablets of losartan 50 mg to $7, $9 [3]. GoodRx coupons cannot be combined with insurance in the same transaction, so patients should compare their insurance copay against the GoodRx price before choosing which to use.

Merck's patient assistance program, Merck Helps, provides branded Cozaar at no cost to patients who meet income eligibility criteria (generally household income at or below 400% of the federal poverty level) and who lack adequate prescription drug coverage [15]. Applications are submitted through Merck's patient assistance portal or through a prescriber's office.

Generic manufacturers including Teva, Aurobindo, and Lupin do not routinely offer consumer-facing savings cards for losartan given the drug's already low cash price. Some telehealth platforms operating in Michigan bundle losartan prescriptions with a pharmacy membership that further reduces cost.

The Inflation Reduction Act's $35/month insulin cap does not extend to losartan, but the law's negotiation provisions and the broader Medicare restructuring do affect how Part D plans design their formularies, occasionally resulting in lower copays for drugs in the same therapeutic category [8].

Telehealth Prescribing of Losartan in Michigan

Michigan law permits telehealth prescribing of losartan for established patients. The Michigan Department of Licensing and Regulatory Affairs (LARA) and the Michigan Board of Medicine recognize audio-video and, under certain conditions, audio-only telemedicine visits as valid encounters for prescribing non-controlled medications [16].

Losartan is not a controlled substance under federal or Michigan law, so there are no DEA prescribing restrictions to manage. A Michigan-licensed physician, nurse practitioner, or physician assistant can prescribe losartan following a telehealth visit provided they establish a valid patient-provider relationship, which typically means taking a medical history, reviewing relevant records, and performing a clinically adequate assessment [16].

Several telehealth platforms licensed in Michigan, including HealthRX, prescribe losartan following an online blood pressure review and medical history intake. Patients typically need to submit recent blood pressure readings, either from a home monitor or a pharmacy kiosk, before a clinician finalizes the prescription. The FDA recommends blood pressure targets below 130/80 mmHg for most adults with hypertension, per the 2017 ACC/AHA guideline [17].

The HealthRX Michigan Losartan Access Framework recommends the following decision path for new patients:

1. Confirm Michigan residency and active pharmacy coverage status.
2. Submit home blood pressure log (minimum 5 readings over 3 days).
3. Telehealth intake visit with Michigan-licensed clinician (15 minutes).
4. Prescription sent to patient's preferred Michigan pharmacy or mail-order.
5. Follow-up visit at 4 weeks to assess blood pressure response and tolerability.
6. Annual labs (serum creatinine, potassium) per ACC/AHA monitoring recommendations.

This framework aligns with the AHA's 2023 Hypertension Guideline Update, which recommends initiating ARB therapy at 50 mg once daily in most patients and titrating to 100 mg if blood pressure remains above goal at 4 weeks [17].

Common Side Effects and Monitoring That Affect Cost Planning

Losartan's tolerability profile directly affects the total cost of treatment because patients who tolerate it well rarely need add-on medications or dose adjustments. The most clinically significant adverse effects are hyperkalemia and a modest rise in serum creatinine, both of which require periodic lab monitoring [18].

The FDA label for losartan recommends checking serum potassium and creatinine within 1 to 2 weeks of initiation, then periodically thereafter. In patients with stage 3 or 4 chronic kidney disease, monitoring may occur every 3 months [1]. A basic metabolic panel at a Michigan LabCorp or Quest Diagnostics location costs $15, $40 on a cash-pay basis, or $0, $10 under most insurance plans.

Losartan does not cause the dry cough associated with ACE inhibitors, which is the primary reason patients switch from lisinopril or enalapril to losartan [14]. This tolerability advantage reduces downstream costs associated with alternative prescriptions and additional clinical visits. A 2020 analysis in JAMA Internal Medicine found that ACE inhibitor-related cough accounts for roughly 10% of all antihypertensive drug switches in the United States, at an estimated $1.2 billion in annual healthcare system costs [19].

Angioedema is rare with ARBs but possible, particularly in patients with a prior ACE inhibitor-related angioedema history. The FDA label carries a warning that losartan should be used with caution in this population [1]. Pregnancy is an absolute contraindication; losartan carries FDA Pregnancy Category D labeling and must not be used in the second or third trimester [1].

Michigan-Specific Discount and Assistance Programs

Beyond GoodRx and Merck Helps, Michigan residents have access to several state-specific pharmaceutical assistance resources.

The Michigan Department of Health and Human Services operates the Michigan Rx program, which provides co-payment assistance for certain drugs to low-income seniors not yet eligible for Medicare or enrolled in a gap-coverage plan [5]. Losartan may qualify under this program for eligible Michigan residents aged 65 and older with household incomes below 200% of the federal poverty level.

Area Agency on Aging (AAA) offices across Michigan's 16 planning and service areas can connect patients with NeedyMeds, Partnership for Prescription Assistance, and RxAssist databases, all of which list manufacturer and non-profit assistance programs for losartan and other cardiometabolic drugs. The National Council on Aging's BenefitsCheckUp tool is another resource that screens Michigan residents for prescription drug assistance eligibility online at no cost [20].

Community health centers operating under HRSA's Federally Qualified Health Center (FQHC) designation in Michigan are required to offer losartan at the 340B discounted price, which is typically below $5 for a 30-day supply for qualifying low-income patients [20]. Michigan has more than 60 FQHC sites, concentrated in Detroit, Grand Rapids, Flint, Lansing, and Pontiac.

Patients who have been uninsured for more than 90 days may also qualify for free medication through NeedyMeds' drug company patient assistance programs. Eligibility and enrollment take 2 to 4 weeks, so patients should pursue this option alongside a short-term GoodRx purchase at the $7, $10 cash price to avoid gaps in therapy [15].

For most Michigan patients who are uninsured and do not qualify for Medicaid, the practical answer is straightforward: buy 90 days of generic losartan at Costco or Sam's Club using the pharmacy's internal pricing, which often undercuts even GoodRx for 90-tablet quantities, bringing the effective monthly cost to approximately $3.